Celera Genomics said Immunex had purchased 5-year subscriptions to several of its genomic databases.
Details of the transaction were not disclosed, but earlier subscribers to Celera’s databases have reportedly paid between $25 million and $50 million for three- to five-year periods.
Based in Seattle, Immunex markets the arthritis drug Enbrel.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
